8-KItem 5.02 · Officer/Director ChangeItem 9.01 · Financial Statements
Pfizer appoints Cecile Guegan as chief financial officer
Filed with the SEC on · Summarized by InvestorsBot
Pfizer’s board unanimously appointed Cecile Guegan as chief financial officer and executive vice president, effective November 1, 2026, after she served as interim CFO since August 16. Guegan, who has more than 25 years of pharmaceutical finance experience, will receive an annual base salary of $1.3 million and a target cash incentive of $1.3 million.